Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H U Bryant

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Journal of Women'S Health|November 14, 1997
Selective estrogen receptor modulators and postmenopausal women's healthT Hol, M B Cox, H U Bryant, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
An estrogen receptor basis for raloxifene action in boneH U Bryant, A L Glasebrook, N N Yang, et al.
Endocrinology|October 1, 1996
Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopeniaG L Evans, H U Bryant, D E Magee, et al.
Endocrinology|May 1, 1997
Clomiphene prevents cancellous bone loss from tibia of ovariectomized ratsM A Jimenez, D E Magee, H U Bryant, et al.
Endocrinology|May 1, 1994
The effects of raloxifene on tibia histomorphometry in ovariectomized ratsG Evans, H U Bryant, D Magee, et al.
Bone|October 1, 1995
Dual-energy X-ray absorptiometry in sheep: experiences with in vivo and ex vivo studiesA S Turner, C H Mallinckrodt, M R Alvis, et al.
Appetite|March 1, 1984
Stress, endogenous opioids and salt intakeC C Kuta, H U Bryant, J E Zabik, et al.
Biochemical Pharmacology|October 1, 1988
Stress- and morphine-induced elevations of plasma and tissue cholesterol in mice: reversal by naltrexoneH U Bryant, C C Kuta, J A Story, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Anti-inflammatory activity of pergolide, a dopamine receptor agonistA M Bendele, S M Spaethe, D N Benslay, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1988
Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing ratsT D Steele, H U Bryant, P V Malven, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Journal of Women'S Health|November 14, 1997
Selective estrogen receptor modulators and postmenopausal women's healthT Hol, M B Cox, H U Bryant, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
An estrogen receptor basis for raloxifene action in boneH U Bryant, A L Glasebrook, N N Yang, et al.
Endocrinology|October 1, 1996
Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopeniaG L Evans, H U Bryant, D E Magee, et al.
Endocrinology|May 1, 1997
Clomiphene prevents cancellous bone loss from tibia of ovariectomized ratsM A Jimenez, D E Magee, H U Bryant, et al.
Endocrinology|May 1, 1994
The effects of raloxifene on tibia histomorphometry in ovariectomized ratsG Evans, H U Bryant, D Magee, et al.
Bone|October 1, 1995
Dual-energy X-ray absorptiometry in sheep: experiences with in vivo and ex vivo studiesA S Turner, C H Mallinckrodt, M R Alvis, et al.
Appetite|March 1, 1984
Stress, endogenous opioids and salt intakeC C Kuta, H U Bryant, J E Zabik, et al.
Biochemical Pharmacology|October 1, 1988
Stress- and morphine-induced elevations of plasma and tissue cholesterol in mice: reversal by naltrexoneH U Bryant, C C Kuta, J A Story, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Anti-inflammatory activity of pergolide, a dopamine receptor agonistA M Bendele, S M Spaethe, D N Benslay, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1988
Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing ratsT D Steele, H U Bryant, P V Malven, et al.
Pageof 7